CDK9 a Potential Target for Drug Development

E-ISSN： 1875-6638|4|3|210-218

ISSN： 1573-4064

Source： Medicinal Chemistry, Vol.4, Iss.3, 2008-05, pp. : 210-218

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Perspective of Cyclin-dependent kinase 9 (CDK9) as a Drug Target

Current Pharmaceutical Design, Vol. 18, Iss. 20, 2012-07 ,pp. : 2883-2890

Bentham Science Publishers

Access to resources Recommend Favorite

Drug-Target Pharmacogenomics: The potential to revolutionize drug discovery and development

Pharmaceutical Innovation, Vol. 11, Iss. 4, 2002-06 ,pp. : 30-37

Adis International

Access to resources Recommend Favorite

Approaches to a Multitargeting Drug Development: First Profiled 3- Ethoxycarbonyl-1-aza-9-oxafluorenes Representing a Perspective Compound Class Targeting Alzheimer Disease Relevant Kinases CDK1, CDK5 and GSK-3&bgr;

Medicinal Chemistry, Vol. 10, Iss. 1, 2014-02 ,pp. : 90-97

Bentham Science Publishers

Access to resources Recommend Favorite

Microfilament Actin Remodeling as a Potential Target for Cancer Drug Development

Current Cancer Drug Targets, Vol. 4, Iss. 4, 2004-06 ,pp. : 345-354

Bentham Science Publishers

Access to resources Recommend Favorite

CDK9/cyclin T1: a host cell target for antiretroviral therapy

By Klebl Bert M Choidas Axel

Future Virology, Vol. 1, Iss. 3, 2006-05 ,pp. : 317-330

Future Medicine

Access to resources Recommend Favorite